National Health (Originator Brand) Determination 2015
PB 100 of 2015
made under subsection 99ADB(6B) of the
National Health Act 1953
Compilation No. 61
Compilation date: 1 June 2024
Includes amendments: F2024L00610
Registered: 6 June 2024
About this compilation
This compilation
This is a compilation of the National Health (Originator Brand) Determination 2015 that shows the text of the law as amended and in force on 1 June 2024 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Editorial changes
For more information about any editorial changes made in this compilation, see the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law.
Self‑repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Contents
1 Name of Determination
3 Definition
4 Originator Brand
Schedule 1—Originator Brand
Endnotes
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
(1) This Determination is the National Health (Originator Brand) Determination 2015.
(2) This Determination may also be cited as PB 100 of 2015.
In this Determination:
Act means the National Health Act 1953.
(1) For subsection 99ADB(6B) of the Act, unless subsections (2) or (3) of this section apply, an originator brand specified in column 3 of an item in Schedule 1 is an originator brand for all brands of pharmaceutical item containing the drug specified in column 2 of the same item in Schedule 1.
(2) Where a manner of administration is specified in column 4 of an item in Schedule 1, an originator brand specified in column 3 of that item in Schedule 1 is an originator brand for all brands of pharmaceutical item containing the drug specified in column 1, with the manner of administration specified in column 4 of the same item in Schedule 1.
(3) Where a form is specified in column 5 of an item in Schedule 1, an originator brand specified in column 3 of that item in Schedule 1 is an originator brand for all brands of pharmaceutical item containing the drug specified in column 2, with the manner of administration specified in column 4 in the form specified in column 5 of the same item in Schedule 1.
Note: A brand of an exempt item is not an originator brand due to section 99ADA of the Act.
(section 4)
Column 1 | Column 2 | Column 3 | Column 4 | Column 5 | |
Item | Drug | Originator Brand | Manner of administration | Form | |
1 | Abacavir with Lamivudine | Kivexa |
|
| |
1A | Abatacept | Orencia Orencia Clickject |
|
| |
1B | Acamprosate | Campral |
|
| |
1C | Acarbose | Glucobay 50 Glucobay 100 |
|
| |
1D | Aciclovir | Zovirax Zovirax 200 mg Zovirax 800 mg |
|
| |
2 | Acitretin | Neotigason |
|
| |
2A | Adalimumab | Humira |
|
| |
3 | Adefovir | Hepsera |
|
| |
3A | Adrenaline (epinephrine) | EpiPen EpiPen Jr. |
|
| |
4 | Alendronic acid with colecalciferol | Fosamax Plus Fosamax Plus 70 mg/140 mcg |
|
| |
5 | Alendronic acid with colecalciferol and calcium | Fosamax Plus D‑Cal |
|
| |
6 | Allopurinol | Zyloprim |
|
| |
Aluminium Hydroxide with Magnesium Hydroxide | Mylanta P |
|
| ||
7A | Amantadine | Symmetrel 100 |
|
| |
7B | Ambrisentan | Volibris |
|
| |
8 | Amiodarone | Cordarone X 100 Cordarone X 200 |
|
| |
9 | Amisulpride | Solian 100 Solian 200 Solian 400 |
|
| |
10 | Amlodipine | Norvasc |
|
| |
11 | Amlodipine with Atorvastatin | Caduet 5/10 Caduet 5/20 Caduet 5/40 Caduet 5/80 Caduet 10/10 Caduet 10/20 Caduet 10/40 Caduet 10/80 |
|
| |
12 | Amlodipine with valsartan | Exforge 5/80 Exforge 5/160 Exforge 5/320 Exforge 10/160 Exforge 10/320 |
|
| |
13 | Amlodipine with valsartan and hydrochlorothiazide | Exforge HCT 5/160/12.5 Exforge HCT 5/160/25 Exforge HCT 10/160/12.5 Exforge HCT 10/160/25 Exforge HCT 10/320/25 |
|
| |
14 | Amoxicillin | Amoxil Amoxil Forte |
|
| |
15 | Amoxicillin with clavulanic acid | Augmentin Augmentin Duo Augmentin Duo 400 Augmentin Duo forte |
|
| |
16 | Anastrozole | Arimidex |
|
| |
16A | Apomorphine | Apomine Apomine Intermittent Apomine Solution for Infusion |
|
| |
16B | Aprepitant | Aprepitant APOTEX |
|
| |
16C | Aripiprazole | Abilify | Oral |
| |
|
| Abilify Maintena | Injection |
| |
16D | Arsenic | Phenasen |
|
| |
16E | Atazanavir | Reyataz |
|
| |
17 | Atenolol | Tenormin |
|
| |
17A | Atomoxetine | Strattera |
|
| |
18 | Atorvastatin | Lipitor |
|
| |
18A | Atovaquone with proguanil | Malarone |
|
| |
18B | Azacitidine | Vidaza |
|
| |
19 | Azathioprine | Imuran |
|
| |
20 | Azithromycin | Zithromax |
|
| |
21 | Baclofen | Lioresal Intrathecal Lioresal 10 Lioresal 25 |
|
| |
21A | Bendamustine | Ribomustin |
|
| |
22 | Betamethasone | Diprosone | Application |
| |
Celestone Chronodose | Injection |
| |||
23 | Betaxolol | Betoptic Betoptic S |
|
| |
23A | Bevacizumab | Avastin |
|
| |
24 | Bicalutamide | Cosudex |
|
| |
24A | Bimatoprost | Lumigan Lumigan PF |
|
| |
25 | Bisoprolol | Bicor |
|
| |
25A | Bivalirudin | Angiomax |
|
| |
25B | Bortezomib | Velcade |
|
| |
25C | Bosentan | Tracleer |
|
| |
26 | Brimonidine | Alphagan Alphagan P 1.5 |
|
| |
27 | Brinzolamide | Azopt |
|
| |
28 | Bromocriptine | Parlodel |
|
| |
28A | Budesonide with formoterol | Symbicort Rapihaler 50/3 Symbicort Rapihaler 100/3 Symbicort Rapihaler 200/6 Symbicort Turbuhaler 100/6 Symbicort Turbuhaler 200/6 Symbicort Turbuhaler 400/12 |
|
| |
28B | Buprenorphine | Buvidal Monthly Buvidal Weekly | Injection |
| |
|
| Subutex | Sublingual |
| |
|
| Norspan | Transdermal |
| |
29 | Bupropion | Zyban |
|
| |
29A | Cabazitaxel | Jevtana |
|
| |
30 | Cabergoline | Cabaser Dostinex |
|
| |
30A | Calcipotriol with betamethasone | Daivobet Daivobet 50/500 gel |
|
| |
31 | Calcitriol | Rocaltrol |
|
| |
32 | Candesartan | Atacand |
|
| |
33 | Candesartan with Hydrochlorothiazide | Atacand Plus 16/12.5 Atacand Plus 32/12.5 Atacand Plus 32/25 |
|
| |
34 | Capecitabine | Xeloda |
|
| |
35 | Captopril | Capoten |
|
| |
36 | Carbamazepine | Tegretol 100 Tegretol 200 Tegretol CR 200 Tegretol CR 400 |
|
| |
36A | Carbimazole | Neo‑Mercazole |
|
| |
37 | Carbomer | Viscotears Viscotears Gel PF |
|
| |
38 | Carvedilol | Dilatrend 3.125 Dilatrend 6.25 Dilatrend 12.5 Dilatrend 25 |
|
| |
39 | Cefaclor | Ceclor Ceclor CD |
|
| |
39A | Cefalexin | Keflex |
|
| |
39B | Cefuroxime | Zinnat |
|
| |
40 | Celecoxib | Celebrex |
|
| |
41 | Certolizumab pegol | Cimzia |
|
| |
41A | Chorionic gonadotrophin | Pregnyl |
|
| |
41B | Ciclosporin | Ikervis | Application to the Eye |
| |
|
| Neoral 25 Neoral 50 Neoral 100 |
|
| |
41C | Cinacalcet | Pharmacor Cinacalcet |
|
| |
42 | Ciprofloxacin | Ciproxin 250 Ciproxin 500 | Oral |
| |
Ciloxan | Application to the eye | ||||
43 | Citalopram | Cipramil |
|
| |
44 | Clarithromycin | Klacid |
|
| |
45 | Clindamycin | Dalacin C |
|
| |
46 | Clomifene | Clomid |
|
| |
47 | Clomipramine | Anafranil 25 |
|
| |
48 | Clonazepam | Rivotril |
|
| |
48A | Clonidine | Catapres 100 Catapres |
|
| |
49 | Clopidogrel | Iscover Plavix |
|
| |
50 | Clopidogrel with aspirin | CoPlavix DuoCover |
|
| |
51 | Clozapine | Clozaril 25 Clozaril 100 |
|
| |
52 | Codeine with Paracetamol | Panadeine Forte |
|
| |
53 | Colchicine | Colgout |
|
| |
54 | Cyclophosphamide | Endoxan |
|
| |
55 | Cyproterone | Androcur Androcur‑100 |
|
| |
55A | Dabigatran etexilate | Pradaxa |
|
| |
55B | Darunavir | Prezista |
|
| |
55C | Dasatinib | Sprycel |
|
| |
55D | Deferasirox | Jadenu |
|
| |
56 | Desferrioxamine | Desferal 500 mg |
|
| |
57 | Desvenlafaxine | Pristiq |
|
| |
58 | Dexamethasone | Maxidex | Application to the Eye |
| |
Ozurdex | Implantation |
| |||
59 | Dexamethasone with Framycetin and Gramicidin | Sofradex |
|
| |
60 | Diazepam | Valium |
|
| |
61 | Diclofenac | Voltaren 25 Voltaren 50 |
|
| |
62 | Digoxin | Lanoxin–PG Lanoxin |
|
| |
63 | Diltiazem | Cardizem Cardizem CD |
|
| |
63A | Dimethyl fumarate | Tecfidera |
|
| |
64 | Diphenoxylate with Atropine | Lomotil |
|
| |
65 | Dipyridamole with Aspirin | Asasantin SR |
|
| |
66 | Docetaxel | Taxotere |
|
| |
66A | Domperidone | Motilium |
|
| |
67 | Donepezil | Aricept |
|
| |
68 | Dorzolamide | Trusopt |
|
| |
69 | Dorzolamide with timolol | Cosopt |
|
| |
70 | Doxorubicin – Pegylated Liposomal | Caelyx |
|
| |
71 | Duloxetine | Cymbalta |
|
| |
71A | Dutasteride | Avodart |
|
| |
71B | Dutasteride with tamsulosin | Duodart 500ug/400ug |
|
| |
72 | Electrolyte Replacement, Oral | Repalyte New Formulation |
|
| |
73 | Enalapril | Renitec Renitec 20 |
|
| |
74 | Enalapril with Hydrochlorothiazide | Renitec Plus 20/6 |
|
| |
74A | Enoxaparin | Clexane Clexane Safety‑Lock |
|
| |
74B | Entecavir | Baraclude |
|
| |
74C | Eplerenone | Inspra |
|
| |
75 | Epoprostenol | Flolan Flolan Kit |
|
| |
76 | Eprosartan | Teveten |
|
| |
76A | Erlotinib | Tarceva |
|
| |
77 | Escitalopram | Lexapro |
|
| |
78 | Esomeprazole | Nexium |
|
| |
78A | Esomeprazole and clarithromycin and amoxicillin | Nexium Hp7 |
|
| |
78B | Estradiol | Progynova |
|
| |
78C | Etanercept | Enbrel |
|
| |
79 | Etoposide | Vepesid | Oral |
| |
Etopophos | Injection | ||||
79A | Everolimus | Afinitor Certican |
|
| |
80 | Exemestane | Aromasin |
|
| |
80A | Ezetimibe | Ezetrol |
|
| |
80B | Ezetimibe and rosuvastatin | Rosuzet Composite Pack |
|
| |
80C | Ezetimibe with atorvastatin | Atozet |
|
| |
80D | Ezetimibe with simvastatin | Vytorin |
|
| |
81 | Famciclovir | Famvir |
|
| |
82 | Felodipine | Plendil ER |
|
| |
82A | Fenofibrate | Lipidil |
|
| |
83 | Fentanyl | Abstral | Sublingual |
| |
Actiq | Buccal | ||||
Durogesic 12 Durogesic 25 Durogesic 50 Durogesic 75 Durogesic 100 | Transdermal | ||||
84 | Filgrastim | Neupogen |
|
| |
84A | Fingolimod | Gilenya |
|
| |
85 | Flecainide | Tambocor |
|
| |
86 | Fluconazole | Diflucan |
|
| |
87 | Fludarabine | Fludara |
|
| |
87A | Fludrocortisone | Florinef |
|
| |
88 | Fluoxetine | Prozac 20 Prozac Tab |
|
| |
88A | Fluticasone propionate | Flixotide Flixotide Accuhaler Flixotide Junior Flixotide Junior Accuhaler |
|
| |
88B | Fluticasone propionate with salmeterol | Seretide Accuhaler 100/50 Seretide Accuhaler 250/50 Seretide Accuhaler 500/50 Seretide MDI 50/25 Seretide MDI 125/25 Seretide MDI 250/25 |
|
| |
89 | Fluvastatin | Lescol XL |
|
| |
90 | Fluvoxamine | Luvox |
|
| |
91 | Folinic acid | Leucovorin Calcium (Hospira Pty Limited) |
|
| |
91A | Follitropin Alfa | Gonal‑f Pen |
|
| |
91B | Follitropin beta | Puregon 300 IU/0.36 mL Puregon 600 IU/0.72 mL Puregon 900 IU/1.08 mL |
|
| |
91C | Fosaprepitant | Emend IV |
|
| |
92 | Fosinopril | Monopril |
|
| |
93 | Fosinopril with Hydrochlorothiazide | Monoplus 10/12.5 Monoplus 20/12.5 |
|
| |
93A | Fulvestrant | Fulvestrant Sandoz |
|
| |
94 | Furosemide | Lasix Lasix‑M |
|
| |
95 | Gabapentin | Neurontin |
|
| |
96 | Galantamine | Reminyl |
|
| |
96A | Ganciclovir | Cymevene |
|
| |
96B | Ganirelix | Orgalutran |
|
| |
96C | Gefitinib | Iressa |
|
| |
97 | Gentamicin | Genoptic |
|
| |
97A | Glatiramer | Copaxone |
|
| |
98 | Glibenclamide | Daonil |
|
| |
99 | Gliclazide | Diamicron 60mg MR |
|
| |
100 | Glimepiride | Amaryl |
|
| |
101 | Glipizide | Minidiab |
|
| |
102 | Glucose | Baxter Healthcare Pty Ltd |
|
| |
103 | Glyceryl Trinitrate | Anginine Stabilised | Buccal/sublingual |
| |
Transiderm‑Nitro 25 Transiderm‑Nitro 50 Nitro‑Dur 5 Nitro‑Dur 10 Nitro‑Dur 15 | Transdermal | ||||
104 | Granisetron | Kytril |
|
| |
105 | Hydrochlorothiazide with Amiloride | Moduretic |
|
| |
106 | Hydrocortisone
| Solu‑Cortef | Injection |
| |
Hycor | Application to the eye |
| |||
106A | Hydromorphone | Dilaudid Dilaudid‑HP | Injection |
| |
Dilaudid Jurnista | Oral |
| |||
106B | Hydroxycarbamide | Hydrea |
|
| |
107 | Hydroxychloroquine | Plaquenil |
|
| |
107A | Hyoscine | Buscopan |
|
| |
108 | Hypromellose with Carbomer 980 | Genteal gel |
|
| |
109 | Hypromellose with Dextran | Tears Naturale |
|
| |
109A | Ibuprofen | Brufen |
|
| |
109B | Icatibant | Firazyr |
|
| |
110 | Idarubicin | Zavedos Zavedos Solution |
|
| |
110A | Imatinib | Glivec |
|
| |
111 | Imipramine | Tofranil 10 Tofranil 25 |
|
| |
112 | Imiquimod | Aldara Aldara Pump |
|
| |
113 | Indapamide | Natrilix Natrilix SR |
|
| |
114 | Indometacin | Indocid |
|
| |
114A | Infliximab | Remicade |
|
| |
114B | Insulin glargine | Lantus Lantus SoloStar Toujeo SoloStar |
|
| |
115 | Interferon Beta‑1b | Betaferon |
|
| |
116 | Ipratropium | Atrovent Atrovent Adult |
|
| |
117 | Irbesartan | Avapro Karvea |
|
| |
118 | Irbesartan with Hydrochlorothiazide | Avapro HCT 150/12.5 Avapro HCT 300/12.5 Avapro HCT 300/25 Karvezide 150/12.5 Karvezide 300/12.5 Karvezide 300/25 |
|
| |
119 | Isosorbide Dinitrate | Isordil Sublingual |
|
| |
120 | Isosorbide Mononitrate | Imdur Durule Imdur 120 mg |
|
| |
121 | Isotretinoin | Roaccutane |
|
| |
121A | Itraconazole | Sporanox Lozanoc |
|
| |
121B | Ivabradine | Coralan |
|
| |
122 | Ketoprofen | Orudis SR 200 |
|
| |
123 | Labetalol | Trandate |
|
| |
123A | Lacosamide | Vimpat |
|
| |
124 | Lamivudine | Zeffix 3TC |
|
| |
125 | Lamivudine with Zidovudine | Combivir |
|
| |
126 | Lamotrigine | Lamictal |
|
| |
126A | Lanreotide | Somatuline Autogel |
|
| |
127 | Lansoprazole | Zoton FasTabs |
|
| |
128 | Latanoprost | Xalatan |
|
| |
129 | Latanoprost with timolol | Xalacom |
|
| |
130 | Leflunomide | Arava |
|
| |
130A | Lenalidomide | Revlimid |
|
| |
131 | Lercanidipine | Zanidip |
|
| |
132 | Letrozole | Femara 2.5 mg |
|
| |
133 | Levetiracetam | Keppra |
|
| |
134 | Levodopa with Carbidopa | Sinemet Sinemet 100/25 | Oral |
| |
Duodopa | Intra‑intestinal |
| |||
134A | Levodopa with carbidopa and entacapone | Stalevo 50/12.5/200mg Stalevo 75/18.75/200mg Stalevo 100/25/200mg Stalevo 125/31.25/200mg Stalevo 150/37.5/200mg Stalevo 200/50/200mg |
|
| |
135 | Levonorgestrel with ethinyestradiol | Microgynon 50 ED | Oral | Pack containing 21 tablets 125 micrograms‑50 micrograms and 7 inert tablets | |
|
| Microgynon 30 ED Nordette 28 | Oral | Pack containing 21 tablets 150 micrograms‑30 micrograms and 7 inert tablets | |
|
| Triphasil 28 Triquilar ED | Oral | Pack containing 6 tablets 50 micrograms‑30 micrograms, 5 tablets 75 micrograms‑40 micrograms, 10 tablets 125 micrograms‑30 micrograms and 7 inert tablets | |
135A | Levothyroxine | Oroxine |
|
| |
135B | Lincomycin | Lincocin |
|
| |
136 | Lisinopril | Zestril Prinivil 10 Prinivil 20 |
|
| |
137 | Loperamide | Imodium |
|
| |
138 | Losartan | Cozavan |
|
| |
138A | Lurasidone | Latuda |
|
| |
139 | Macrogol 3350 | Movicol Liquid Movicol |
|
| |
140 | Medroxyprogesterone | Provera Depo‑Provera |
|
| |
140A | Mefenamic acid | Ponstan |
|
| |
141 | Meloxicam | Mobic |
|
| |
142 | Memantine | Ebixa |
|
| |
142A | Mercaptopurine | Purinethol |
|
| |
Mesalazine | Pentasa | Rectal | Enemas 1 g in 100 mL, 7 | ||
| Salofalk | Rectal | Enemas 2 g in 60 mL, 7 | ||
|
| Salofalk | Rectal | Enemas 4 g in 60 mL, 7 | |
| Salofalk | Rectal | Rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g | ||
|
| Salofalk | Rectal | Suppository (moulded) 1 g | |
|
| Pentasa | Rectal | Suppository 1 g | |
|
| Salofalk | Oral | Sachet containing granules, 500 mg per sachet | |
|
| Salofalk | Oral | Sachet containing granules, 1 g per sachet | |
|
| Pentasa | Oral | Sachet containing prolonged release granules, 1 g per sachet | |
|
| Salofalk | Oral | Sachet containing granules, 1.5 g per sachet | |
|
| Pentasa | Oral | Sachet containing prolonged release granules, 2 g per sachet | |
|
| Salofalk | Oral | Sachet containing granules, 3 g per sachet | |
|
| Pentasa | Oral | Sachet containing prolonged release granules, 4 g per sachet | |
|
| Mesasal | Oral | Tablet 250 mg (enteric coated) | |
|
| Salofalk | Oral | Tablet 500 mg (enteric coated) | |
|
| Pentasa | Oral | Tablet 500 mg (prolonged release) | |
|
| Asacol | Oral | Tablet 800 mg (enteric coated) | |
|
| Salofalk | Oral | Tablet 1 g (enteric coated) | |
|
| Pentasa | Oral | Tablet 1 g (prolonged release) | |
|
| Mezavant | Oral | Tablet 1.2 g (prolonged release) | |
|
| Asacol | Oral | Tablet 1.6 g (enteric coated) | |
143 | Metformin | Diabex Diabex 850 Diabex 1000 Diabex XR 500 Diabex XR 1000 |
|
| |
144 | Methadone | Physeptone |
|
| |
144A | Methenamine | Hiprex |
|
| |
145 | Methyldopa | Aldomet |
|
| |
146 | Methylphenidate | Ritalin 10 Ritalin LA |
|
| |
147 | Methylprednisolone | Advantan Advantan (Fatty) | Application |
| |
|
| Depo‑Medrol Solu‑Medrol |
|
| |
148 | Metoclopramide | Maxolon |
|
| |
149 | Metoprolol | Betaloc Lopresor 50 Lopresor 100 |
|
| |
150 | Metoprolol succinate | Toprol‑XL 23.75 Toprol‑XL 47.5 Toprol‑XL 95 Toprol‑XL 190 |
|
| |
151 | Metronidazole | Flagyl |
|
| |
152 | Minocycline | Minomycin‑50 |
|
| |
153 | Moclobemide | Aurorix Aurorix 300 mg |
|
| |
153A | Modafinil | Modavigil |
|
| |
154 | Mometasone | Elocon Elocon Alcohol Free |
|
| |
155 | Montelukast | Singulair |
|
| |
156 | Morphine | DBL Morphine Sulfate Pentahydrate | Injection |
| |
|
| MS Contin MS Contin Suspension 100 mg MS Contin Suspension 20 mg MS Contin Suspension 200 mg MS Contin Suspension 30 mg MS Contin Suspension 60 mg |
|
| |
156A | Moxonidine | Physiotens |
|
| |
157 | Mycophenolic Acid | Myfortic CellCept |
|
| |
157A | Naloxone | Naloxone Hydrochloride (DBL) | Injection |
| |
|
| Nyxoid | Nasal |
| |
158 | Naltrexone | ReVia |
|
| |
159 | Naproxen | Naprosyn Naprosyn SR750 Naprosyn SR1000 |
|
| |
159A | Nebivolol | Nebilet |
|
| |
160 | Nevirapine | Viramune Viramune XR |
|
| |
161 | Nicorandil | Ikorel |
|
| |
162 | Nifedipine | Adalat 10 Adalat 20 Adalat Oros 20mg Adalat Oros 30 Adalat Oros 60 |
|
| |
163 | Nitrazepam | Mogadon |
|
| |
163A | Nitrofurantoin | Macrodantin |
|
| |
164 | Nizatidine | Tazac |
|
| |
165 | Norethisterone | Micronor Noriday 28 day Primolut N |
|
| |
166 | Norethisterone with ethinylestradiol | Brevinor Brevinor‑1 |
|
| |
166A | Nortriptyline | Allegron |
|
| |
167 | Octreotide | Sandostatin 0.05 Sandostatin 0.1 Sandostatin 0.5 Sandostatin LAR |
|
| |
169 | Olanzapine | Zyprexa Zyprexa Zydis Zyprexa Relprevv |
|
| |
170 | Olmesartan | Olmetec |
|
| |
170A | Olmesartan with amlodipine | Sevikar 20/5 Sevikar 40/5 Sevikar 40/10 |
|
| |
170B | Olmesartan with amlodipine and hydrochlorothiazide | Sevikar HCT 20/5/12.5 Sevikar HCT 40/10/12.5 Sevikar HCT 40/10/25 Sevikar HCT 40/5/12.5 Sevikar HCT 40/5/25 |
|
| |
170C | Olmesartan with hydrochlorothiazide | Olmetec Plus |
|
| |
171 | Omalizumab | Xolair |
|
| |
172 | Omeprazole | Losec Tablets |
|
| |
173 | Ondansetron | Zofran Zofran Zydis |
|
| |
174 | Oxaliplatin | Eloxatin |
|
| |
175 | Oxazepam | Serepax |
|
| |
176 | Oxybutynin | Ditropan |
|
| |
177 | Oxycodone | Endone OxyNorm OxyContin | Oral |
| |
Proladone | Rectal |
| |||
177A | Palonosetron | Aloxi |
|
| |
178 | Pamidronic Acid | Aredia 30 mg Aredia 90 mg |
|
| |
179 | Pantoprazole | Somac |
|
| |
180 | Paracetamol | Panadol Osteo |
|
| |
181 | Paroxetine | Aropax |
|
| |
181A | Pegfilgrastim | Neulasta |
|
| |
181B | Pemetrexed | Alimta |
|
| |
182 | Perindopril | Coversyl 2.5mg Coversyl 5mg Coversyl 10mg |
|
| |
183 | Perindopril with amlodipine | Coveram 5/5 Coveram 5/10 Coveram 10/5 Coveram 10/10 |
|
| |
184 | Perindopril with indapamide | Coversyl Plus LD 2.5mg/0.625mg Coversyl Plus 5mg/1.25mg |
|
| |
185 | Pindolol | Visken 15 |
|
| |
186 | Pioglitazone | Actos |
|
| |
187 | Piroxicam | Feldene Feldene‑D |
|
| |
187A | Plerixafor | Mozobil |
|
| |
188 | Polyethylene glycol 400 with propylene glycol | Systane |
|
| |
188A | Polyvinyl Alcohol | Liquifilm Tears |
|
| |
188B | Pomalidomide | Pomalyst |
|
| |
188C | Posaconazole | Noxafil |
|
| |
189 | Pramipexole | Sifrol Sifrol ER |
|
| |
190 | Pravastatin | Pravachol |
|
| |
191 | Prazosin | Minipress |
|
| |
191A | Pregabalin | Lyrica |
|
| |
192 | Prochlorperazine | Stemetil |
|
| |
193 | Propranolol | Inderal |
|
| |
194 | Quetiapine | Seroquel Seroquel XR |
|
| |
195 | Quinapril | Accupril |
|
| |
196 | Rabeprazole | Pariet |
|
| |
197 | Raloxifene | Evista |
|
| |
198 | Ramipril | Tritace Tritace 1.25 mg Tritace 2.5 mg Tritace 5 mg Tritace 10 mg Tritace Titration Pack |
|
| |
199 | Ranitidine | Zantac |
|
| |
199A | Rasagiline | Azilect |
|
| |
200 | Riluzole | Rilutek |
|
| |
201 | Risedronic Acid | Actonel Actonel EC Actonel Once‑a‑Month |
|
| |
202 | Risedronic Acid and Calcium | Actonel EC Combi |
|
| |
203 | Risedronic acid and calcium with colecalciferol | Actonel EC Combi D |
|
| |
204 | Risperidone | Risperdal Risperdal Quicklet Risperdal Consta |
|
| |
204A | Rituximab | Mabthera Mabthera SC |
|
| |
204B | Rivastigmine
| Exelon | Oral |
| |
Exelon Patch 5 Exelon Patch 10 Exelon Patch 15 | Transdermal |
| |||
204C | Rizatriptan | Maxalt |
|
| |
205 | Rosuvastatin | Crestor |
|
| |
206 | Roxithromycin | Rulide |
|
| |
207 | Salbutamol | Ventolin Rotacaps Ventolin CFC‑free Ventolin CFC‑Free with dose counter Ventolin Nebules |
|
| |
208 | Selegiline | Eldepryl |
|
| |
209 | Sertraline | Zoloft |
|
| |
209A | Sevelamer | Renagel |
|
| |
210 | Sildenafil | Revatio |
|
| |
211 | Simvastatin | Lipex 10 Lipex 20 Lipex 40 Lipex 80 Zocor |
|
| |
211A | Sitagliptin | Januvia |
|
| |
211B | Sitagliptin with metformin | Janumet Janumet XR |
|
| |
211C | Somatropin | Genotropin Genotropin GoQuick Genotropin MiniQuick |
|
| |
212 | Sorbitol with sodium citrate dihydrate and sodium lauryl sulfoacetate | Microlax |
|
| |
213 | Sotalol | Sotacor |
|
| |
214 | Spironolactone | Aldactone |
|
| |
215 | Sucralfate | Carafate |
|
| |
216 | Sulfasalazine | Salazopyrin Salazopyrin‑EN |
|
| |
217 | Sumatriptan | Imigran Imigran FDT |
|
| |
217A | Sunitinib | Sutent |
|
| |
218 | Tacrolimus | Prograf Prograf XL |
|
| |
218A | Tadalafil | Adcirca |
|
| |
219 | Tamoxifen | Nolvadex‑D |
|
| |
220 | Telmisartan | Micardis |
|
| |
221 | Telmisartan with amlodipine | Twynsta |
|
| |
222 | Telmisartan with Hydrochlorothiazide | Micardis Plus 40/12.5 mg Micardis Plus 80/12.5 mg Micardis Plus 80/25 mg |
|
| |
223 | Temazepam | Normison |
|
| |
224 | Temozolomide | Temodal |
|
| |
224A | Tenofovir | Viread |
|
| |
224B | Tenofovir with emtricitabine | Truvada |
|
| |
224C | Tenofovir with emtricitabine and efavirenz | Atripla |
|
| |
225 | Terbinafine | Lamisil (Novartis Pharmaceuticals Australia Pty Limited) |
|
| |
225A | Teriflunomide | Aubagio |
|
| |
225B | Teriparatide | Forteo |
|
| |
225C | Testosterone | Reandron 1000 |
|
| |
226 | Tetrabenazine | iNova Pharmaceuticals (Australia) Pty Ltd |
|
| |
227 | Timolol | Timoptol Timoptol XE |
|
| |
228 | Tinidazole | Fasigyn |
|
| |
228A | Tiotropium | Spiriva Spiriva Respimat |
|
| |
229 | Tirofiban | Aggrastat |
|
| |
229A | Tobramycin | DBL Tobramycin Pfizer Australia Pty Ltd | Injection |
| |
Tobi | Inhalation |
| |||
TOBI podhaler | Inhalation by mouth |
| |||
Tobrex | Application to the eye |
| |||
229B | Tocilizumab | Actemra Actemra ACTPen Actemra Subcutaneous Injection |
|
| |
230 | Topiramate | Topamax Topamax Sprinkle |
|
| |
231 | Topotecan | Hycamtin |
|
| |
232 | Tramadol
| Tramal Tramal SR 50 Tramal SR 100 Tramal SR 150 Tramal SR 200 Tramal 100 |
|
| |
233 | Trandolapril | Gopten |
|
| |
233A | Tranexamic Acid | Cyklokapron |
|
| |
233B | Trastuzumab | Herceptin Herceptin SC |
|
| |
234 | Triamcinolone | Kenacort‑A10 | Injection |
| |
Aristocort 0.02% | Application | ||||
235 | Triamcinolone with Neomycin, Gramicidin and Nystatin | Kenacomb Otic |
|
| |
236 | Trimethoprim | Triprim |
|
| |
237 | Trimethoprim with Sulfamethoxazole | Bactrim Bactrim DS |
|
| |
238 | Ursodeoxycholic Acid | Ursofalk |
|
| |
239 | Valaciclovir | Valtrex |
|
| |
239A | Valganciclovir | Valcyte |
|
| |
240 | Valproic Acid | Epilim EC |
|
| |
241 | Valsartan | Diovan |
|
| |
242 | Valsartan with hydrochlorothiazide | Co‑Diovan 80/12.5 Co‑Diovan 160/12.5 Co‑Diovan 160/25 Co‑Diovan 320/12.5 Co‑Diovan 320/25 |
|
| |
243 | Vancomycin
| Vancocin Vancocin CP |
|
| |
243A | Varenicline | Champix |
|
| |
244 | Venlafaxine | Efexor‑XR |
|
| |
245 | Verapamil | Isoptin Isoptin SR Isoptin 180 SR |
|
| |
246 | Vinorelbine | Navelbine |
|
| |
246A | Voriconazole | Vfend |
|
| |
247 | Ziprasidone | Zeldox |
|
| |
247A | Zoledronic acid | Aclasta Zometa |
|
| |
248 | Zolmitriptan | Zomig |
|
| |
248A | Zonisamide | Zonegran |
|
| |
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.
Editorial changes
The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.
If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.
If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.
ad = added or inserted | o = order(s) |
am = amended | Ord = Ordinance |
amdt = amendment | orig = original |
c = clause(s) | par = paragraph(s)/subparagraph(s) |
C[x] = Compilation No. x | /sub‑subparagraph(s) |
Ch = Chapter(s) | pres = present |
def = definition(s) | prev = previous |
Dict = Dictionary | (prev…) = previously |
disallowed = disallowed by Parliament | Pt = Part(s) |
Div = Division(s) | r = regulation(s)/rule(s) |
ed = editorial change | reloc = relocated |
exp = expires/expired or ceases/ceased to have | renum = renumbered |
effect | rep = repealed |
F = Federal Register of Legislation | rs = repealed and substituted |
gaz = gazette | s = section(s)/subsection(s) |
LA = Legislation Act 2003 | Sch = Schedule(s) |
LIA = Legislative Instruments Act 2003 | Sdiv = Subdivision(s) |
(md) = misdescribed amendment can be given | SLI = Select Legislative Instrument |
effect | SR = Statutory Rules |
(md not incorp) = misdescribed amendment | Sub‑Ch = Sub‑Chapter(s) |
cannot be given effect | SubPt = Subpart(s) |
mod = modified/modification | underlining = whole or part not |
No. = Number(s) | commenced or to be commenced |
Name | Registration | Commencement | Application, saving and transitional provisions |
National Health (Originator Brand) Determination 2015 (PB 100 of 2015) | 29 Sept 2015 (F2015L01525) | 1 Oct 2015 (s 2) |
|
National Health (Originator Brand) Amendment Determination 2015 (No. 1) (PB 114 of 2015) | 1 Dec 2015 (F2015L01905) | 1 Dec 2015 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2015 (No. 2) (PB 127 of 2015) | 24 Dec 2015 (F2015L02140) | 1 Jan 2015 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2016 (No. 1) (PB 8 of 2016) | 1 Feb 2016 (F2016L00083) | 1 Feb 2016 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2016 (No. 2) (PB 27 of 2016) | 1 Apr 2016 (F2016L00471) | 1 Apr 2016 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2016 (No. 3) (PB 38 of 2016) | 29 Apr 2016 (F2016L00606) | 1 May 2016 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2016 (No. 4) (PB 49 of 2016) | 31 May 2016 (F2016L00869) | 1 June 2016 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2016 (No. 5) (PB 71 of 2016) | 28 July 2016 (F2016L01245) | 1 Aug 2016 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2016 (No. 6) (PB 79 of 2016) | 25 Aug 2016 (F2016L01329) | 1 Sept 2016 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2016 (No. 7) (PB 89 of 2016) | 28 Sept 2016 (F2016L01537) | 1 Oct 2016 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2016 (No. 8) (PB 105 of 2016) | 30 Nov 2016 (F2016L01840) | 1 Dec 2016 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2017 (No. 1) (PB 11 of 2017) | 27 Jan 2017 (F2017L00078) | 1 Feb 2017 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2017 (No. 2) (PB 23 of 2017) | 30 Mar 2017 (F2017L00360) | 1 Apr 2017 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2017 (No. 3) (PB 33 of 2017) | 28 Apr 2017 (F2017L00487) | 1 May 2017 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2017 (No. 4) (PB 42 of 2017) | 31 May 2017 (F2017L00632) | 1 June 2017 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2017 (No. 5) (PB 50 of 2017) | 29 June 2017 (F2017L00823) | 1 July 2017 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2017 (No. 6) (PB 61 of 2017) | 27 July 2017 (F2017L00962) | 1 Aug 2017 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2017 (No. 7) (PB 80 of 2017) | 29 Sept 2017 (F2017L01307) | 1 Oct 2017 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2017 (No. 8) (PB 98 of 2017) | 29 Nov 2017 (F2017L01550) | 1 Dec 2017 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2018 (No. 1) (PB 11 of 2018) | 30 Jan 2018 (F2018L00061) | 1 Feb 2018 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2018 (No. 2) (PB 26 of 2018) | 28 Mar 2018 (F2018L00419) | 1 Apr 2018 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2018 (No. 3) (PB 44 of 2018) | 31 May 2018 (F2018L00696) | 1 June 2018 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2018 (No. 4) (PB 60 of 2018) | 29 June 2018 (F2018L00957) | 1 July 2018 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2018 (No. 5) (PB 71 of 2018) | 1 Aug 2018 (F2018L01073) | 1 Aug 2018 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2018 (No. 6) (PB 88 of 2018) | 27 Sept 2018 (F2018L01351) | 1 Oct 2018 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2018 (No. 7) (PB 105 of 2018) | 29 Nov 2018 (F2018L01635) | 1 Dec 2018 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2019 (No. 1) (PB 6 of 2019) | 31 Jan 2019 (F2019L00079) | 1 Feb 2019 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2019 (No. 2) (PB 25 of 2019) | 29 Mar 2019 (F2019L00467) | 1 Apr 2019 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2019 (No. 3) (PB 34 of 2019) | 30 Apr 2019 (F2019L00657) | 1 May 2019 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2019 (No. 4) (PB 42 of 2019) | 31 May 2019 (F2019L00715) | 1 June 2019 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2019 (No. 5) (PB 64 of 2019) | 30 July 2019 (F2019L01017) | 1 Aug 2019 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2019 (No. 6) (PB 73 of 2019) | 30 Aug 2019 (F2019L01121) | 1 Sept 2019 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2019 (No. 7) (PB 82 of 2019) | 30 Sept 2019 (F2019L01292) | 1 Oct 2019 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2019 (No. 8) (PB 90 of 2019) | 31 Oct 2019 (F2019L01396) | 1 Nov 2019 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2019 (No. 9) (PB 99 of 2019) | 27 Nov 2019 (F2019L01512) | 1 Dec 2019 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2020 (No. 1) (PB 9 of 2020) | 31 Jan 2020 (F2020L00077) | 1 Feb 2020 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2020 (No. 2) (PB 27 of 2020) | 31 Mar 2020 (F2020L00362) | 1 Apr 2020 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2020 (No. 3) (PB 49 of 2020) | 29 May 2020 (F2020L00640) | 1 June 2020 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2020 (No. 4) (PB 74 of 2020) | 31 July 2020 (F2020L00970) | 1 Aug 2020 (s 2) | — |
National Health (Originator Brand) Amendment Determination 2020 (No. 5) (PB 85 of 2020) | 28 Aug 2020 (F2020L01086) | 1 Sept 2020 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2020 (No. 6) (PB 96 of 2020) | 30 Sept 2020 (F2020L01257) | 1 Oct 2020 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2020 (No. 7) (PB 118 of 2020) | 27 Nov 2020 (F2020L01491) | 1 Dec 2020 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2021 (No. 1) (PB 7 of 2021) | 28 Jan 2021 (F2021L00082) | 1 Feb 2021 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2021 (No. 2) (PB 34 of 2021) | 31 Mar 2021 (F2021L00394) | 1 Apr 2021 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2021 (No. 3) (PB 55 of 2021) | 28 May 2021 (F2021L00656) | 1 June 2021 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2021 (No. 4) (PB 82 of 2021) | 31 July 2021 (F2021L01063) | 1 Aug 2021 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2021 (No. 5) (PB 104 of 2021) | 30 Sept 2021 (F2021L01368) | 1 Oct 2021 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2021 (No. 6) (PB 116 of 2021) | 31 Oct 2021 (F2021L01490) | 1 Nov 2021 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2021 (No. 7) (PB 126 of 2021) | 30 Nov 2021 (F2021L01640) | 1 Dec 2021 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2022 (No. 1) (PB 8 of 2022) | 31 Jan 2022 (F2022L00085) | 1 Feb 2022 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2022 (No. 2) (PB 30 of 2022) | 31 Mar 2022 (F2022L00460) | 1 Apr 2022 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2022 (No. 3) (PB 76 of 2022) | 29 July 2022 (F2022L01017) | 1 Aug 2022 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2022 (No. 4) (PB 96 of 2022) | 30 Sept 2022 (F2022L01297) | 1 Oct 2022 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2022 (No. 5) (PB 117 of 2022) | 30 Nov 2022 (F2022L01552) | 1 Dec 2022 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2023 (No. 1) (PB 7 of 2023) | 31 Jan 2023 (F2023L00069) | 1 Feb 2023 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2023 (No. 2) (PB 28 of 2023) | 31 Mar 2023 (F2023L00398) | 1 Apr 2023 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2023 (No. 3) (PB 49 of 2023) | 31 May 2023 (F2023L00652) | 1 June 2023 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2023 (No. 4) (PB 75 of 2023) | 31 July 2023 (F2023L01046) | 1 Aug 2023 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2023 (No. 5) (PB 98 of 2023) | 29 Sept 2023 (F2023L01344) | 1 Oct 2023 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2023 (No. 6) (PB 120 of 2023) | 30 Nov 2023 (F2023L01579) | 1 Dec 2023 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2024 (No. 1) (PB 8 of 2024) | 31 Jan 2024 (F2024L00126) | 1 Feb 2024 (s 2(1) item 1) | — |
National Health (Originator Brand) Amendment Determination 2024 (No. 2) (PB 59 of 2024) | 31 May 2024 (F2024L00610) | 1 June 2024 (s 2(1) item 1) | — |
Provision affected | How affected |
s 2..................... | rep LIA s 48D |
Schedule 1 |
|
Schedule 1................ | am F2015L01905; F2015L02140; F2016L00083; F2016L00471; F2016L00606; F2016L00869; F2016L01245; F2016L01329; F2016L01537; F2016L01840; F2017L00078; F2017L00360; F2017L00487; F2017L00632; F2017L00823; F2017L00962; F2017L01307; F2017L01550; F2018L00061; F2018L00419 |
| ed C20 |
| am F2018L00696 |
| ed C21 |
| am F2018L00957; F2018L01073; F2018L01351; F2018L01635; F2019L00079; F2019L00467; F2019L00657; F2019L00715; F2019L01017; F2019L01121; F2019L01292; F2019L01396; F2019L01512; F2020L00077; F2020L00362; F2020L00640; F2020L00970; F2020L01086; F2020L01257; F2020L01491; F2021L00082; F2021L00394; F2021L00656; F2021L01063; F2021L01368; F2021L01490; F2021L01640; F2022L00085; F2022L00460; F2022L01017; F2022L01297 (Sch 1 item 2 md not incorp); F2022L01552; F2023L00069; F2023L00398; F2023L00652; F2023L01046; F2023L01344; F2023L01579; F2024L00126; F2024L00610 |